In an adult male with follicle‑stimulating hormone levels of 10–11 IU/L (reference 1–12.4 IU/L), testicular lengths decreasing from 4 cm to 3.1–3.4 cm on ultrasound, and semen concentrations of 56 and 43 million/mL, does this indicate testicular atrophy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Assessment of Testicular Atrophy in Your Clinical Scenario

Your FSH levels of 10–11 IU/L combined with testicular size reduction from 4 cm to 3.1–3.4 cm and declining sperm concentrations (56 to 43 million/mL) indicate early testicular dysfunction with reduced testicular reserve, but this does NOT represent complete testicular atrophy or failure—you still have normal sperm production that exceeds WHO fertility thresholds. 1

Understanding Your Current Status

FSH Interpretation

  • Your FSH levels (10–11 IU/L) fall in the borderline-elevated range, indicating compensated testicular dysfunction where your pituitary is working harder to maintain sperm production. 1
  • FSH >7.6 IU/L is associated with a 5- to 13-fold higher risk of abnormal sperm parameters compared to FSH <2.8 IU/L, but this reflects impaired spermatogenesis, not absent spermatogenesis. 1, 2
  • Critical distinction: FSH >7.6 IU/L with testicular atrophy typically indicates non-obstructive azoospermia (zero sperm), but your sperm concentration of 43–56 million/mL far exceeds the WHO lower reference limit of 16 million/mL. 1, 3
  • Men can maintain normal sperm counts and fertility despite elevated FSH through compensated primary testicular disease—your case appears to fit this pattern. 3

Testicular Size Assessment

The reported size reduction requires urgent verification due to high likelihood of measurement error:

  • A 4 cm testicular length corresponds to approximately 15–18 mL volume, which is normal and associated with adequate spermatogenesis. 4
  • A 3.1–3.4 cm length would correspond to approximately 6–8 mL volume using proper ultrasound formulas (Length × Width × Height × 0.71), which would represent severe testicular atrophy. 4
  • This dramatic 40–50% volume reduction over a short timeframe is biologically implausible in adults unless acute pathology occurred (torsion, severe trauma, acute orchitis)—none of which you've described. 4
  • Most likely explanation: technical measurement error from improper caliper placement, use of incorrect formula (0.52 ellipsoid formula underestimates by 20–30%), or different measurement techniques between scans. 4

Sperm Production Analysis

Your sperm concentrations are reassuring:

  • 56 million/mL and 43 million/mL both exceed the WHO lower reference limit of 16 million/mL by 2.5–3.5 times. 1
  • With a typical ejaculate volume of 2–3 mL, your total sperm count would be 86–168 million per ejaculate, far exceeding the WHO threshold of 39 million. 1
  • This level of sperm production is inconsistent with severe testicular atrophy (volume <12 mL), which typically produces oligospermia (<15 million/mL) or azoospermia. 1, 5

Essential Next Steps

1. Verify Testicular Measurements Immediately

Request repeat scrotal ultrasound with explicit instructions: 4

  • Use high-frequency probes (>10 MHz) for maximum resolution
  • Measure three perpendicular dimensions (length, width, height) on axial slices
  • Calculate volume using Lambert formula: Length × Width × Height × 0.71
  • Have the same sonographer remeasure the previous scan images to identify measurement discrepancies
  • Compare size discrepancy between right and left testis (>2 mL or 20% difference warrants further evaluation)

2. Complete Hormonal Evaluation

Obtain morning fasting blood tests: 1

  • LH and total testosterone to distinguish primary testicular failure (elevated LH, low-normal testosterone) from secondary hypogonadism (low-normal LH)
  • SHBG to calculate free testosterone index, as high SHBG can reduce bioavailable testosterone despite normal total testosterone
  • Prolactin to exclude hyperprolactinemia, which can disrupt gonadotropin secretion
  • TSH and free T4 because thyroid dysfunction commonly affects reproductive hormones and can cause reversible FSH elevation

3. Repeat Semen Analysis

  • Perform at least one additional semen analysis after 2–3 months to establish whether parameters are stable or declining. 1
  • Single analyses can be misleading due to natural variability (illness, stress, heat exposure, abstinence duration). 1

4. Physical Examination by Reproductive Specialist

Essential examination findings to assess: 1, 6

  • Testicular consistency (firm vs. soft suggests different pathology)
  • Presence of varicocele on standing examination (palpable varicoceles can cause progressive testicular damage and are treatable)
  • Vas deferens and epididymal abnormalities
  • Signs of prior cryptorchidism or testicular trauma

Risk Stratification and Monitoring

You Are NOT in Immediate Danger of Azoospermia

  • Your current sperm production (43–56 million/mL) places you well within the fertile range. 1
  • However, the combination of borderline-elevated FSH and potentially reduced testicular volume indicates reduced testicular reserve, meaning less capacity to compensate if additional stressors occur. 1

Factors That Could Accelerate Decline

Absolutely avoid: 1

  • Exogenous testosterone or anabolic steroids—these will completely suppress spermatogenesis through negative feedback, causing azoospermia that takes months to years to recover
  • Gonadotoxic medications, chemotherapy, or radiation therapy
  • Prolonged heat exposure to testes (hot tubs, saunas, tight underwear, laptop on lap)

Optimize modifiable factors: 1

  • Smoking cessation
  • Maintain healthy body weight (BMI <25)
  • Optimize glycemic control if diabetic
  • Correct thyroid dysfunction if present
  • Treat clinical varicocele if present

Consider Fertility Preservation

If repeat ultrasound confirms testicular volume <12 mL: 1, 6

  • Strongly consider sperm cryopreservation (banking 2–3 separate ejaculates with 2–3 days abstinence between collections)
  • This provides insurance against progressive spermatogenic failure
  • Once azoospermia develops, even microsurgical testicular sperm extraction (micro-TESE) only achieves 40–50% sperm retrieval rates

Genetic Testing Indications

Genetic testing is NOT currently indicated because your sperm concentration exceeds 5 million/mL. 1

However, obtain genetic testing if: 1

  • Sperm concentration drops below 5 million/mL on repeat analysis
  • Karyotype analysis to exclude Klinefelter syndrome (47,XXY)
  • Y-chromosome microdeletion testing (AZFa, AZFb, AZFc regions) if concentration drops below 1 million/mL

Fertility Outlook

Current Fertility Status

  • Your sperm parameters support excellent natural conception potential with total motile sperm count likely >36 million per ejaculate (assuming 50% motility). 1
  • Couples with male total motile sperm count >10 million have good natural conception rates. 1
  • Female partner age is the most critical factor determining conception success—if she is under 30, you have >90% chance of achieving pregnancy within 2–3 years of trying. 1

When to Seek Fertility Assistance

  • If no conception after 12 months of timed intercourse (or 6 months if female partner >35 years). 1
  • If repeat semen analysis shows declining trend approaching 20 million/mL or below. 1
  • IVF/ICSI offers superior pregnancy rates compared to empiric hormonal therapy if parameters worsen. 1

Critical Pitfalls to Avoid

  • Do not accept the ultrasound measurements at face value—the reported size reduction is biologically implausible given your normal sperm production and requires verification. 4
  • Never start testosterone therapy if current or future fertility is desired—it will cause azoospermia. 1
  • Do not delay fertility preservation if repeat ultrasound confirms volume <12 mL and you desire future children. 1, 6
  • FSH levels alone cannot predict fertility status—your actual sperm production is far more important than the FSH number. 1

Summary Assessment

Most likely scenario: You have compensated primary testicular dysfunction with borderline-elevated FSH (10–11 IU/L) maintaining normal sperm production (43–56 million/mL) through increased pituitary drive, combined with probable ultrasound measurement error creating the appearance of dramatic testicular atrophy. 1, 3 True testicular volume <12 mL with this level of sperm production would be highly unusual. 5 Verify measurements, complete hormonal workup, and establish monitoring protocol to detect early decline.

References

Guideline

Non-Obstructive Azoospermia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Testicular Size and Volume Measurement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Sperm Production in Atrophied Testicles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

I have a low sperm count of 50 million per milliliter (mL) in a semen volume of 3.3 mL, elevated Follicle-Stimulating Hormone (FSH) level of 10.4, and small testicles, could I have testicular atrophy?
What is the expected rate of decline in sperm quality and quantity in a male with normal sperm count (80 million/ml) and slightly low testicular volume (12.4ml), planning to conceive within 5 years?
I have testicular atrophy and abnormal hormone levels, but my semen analysis shows normal sperm, what does this mean for my fertility?
What is the clinical significance of a patient's reported testicular shrinkage over 6 months with normal Follicle-Stimulating Hormone (FSH) levels and a semen analysis indicating robust spermatogenesis, given their FSH level is 10.4, within the normal range of 1-12.4, and semen analysis parameters show a sperm concentration of 50-56 million/mL, total count of approximately 188 million, and no decline in motility?
Am I at risk of future decline in testicular function and fertility given my borderline-small testicular volumes and normal hormonal profile?
How should peripheral arterial disease affecting the bilateral dorsalis pedis arteries be managed?
For an elderly patient discharged to a skilled‑nursing facility after hospitalization, how long should prophylactic enoxaparin (Lovenox) be continued?
Is A&D ointment an appropriate first‑line treatment for perianal candidiasis in a patient with fecal incontinence?
What is the proper technique and dosing for intramuscular administration of flumazenil in an adult when intravenous access is unavailable?
Are there seizure types that are unilateral or confined to a single limb?
What is the stepwise evidence‑based treatment for an adult with moderate‑to‑severe plaque psoriasis (≥10% body surface area or significant quality‑of‑life impact)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.